# Addex Therapeutics Ltd.: Form SCHEDULE 13D/A, filed Jun 23, 2025

- Company: [Addex Therapeutics Ltd.](/companies/adxn.md) (CIK 1574232)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-23
- Accepted by EDGAR: Jun 23, 2025, 16:00 ET
- Period: not reported
- Accession: 0001104659-25-061660
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1574232/000110465925061660/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574232/000110465925061660/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574232/000110465925061660/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-061660. Last ingested by Listed: Oct 29, 2026, 06:06 ET. No prices; not investment advice.